Thoracic Neoplasm clinical trials
19 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
- Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
- Effectiveness of Central Oncology Navigation and the Use of an ORN
- Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
- Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
- A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer
- Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
- A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
- Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
- Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
- SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
- Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services
- Feasibility Study of CBCT for IGRT in Cancer Patients
- Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
- Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
- Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
- Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Thoracic Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.